Today: 23 April 2026
Subscribe
Browse Category

NASDAQ:EDIT 2 November 2025 - 9 January 2026

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics shares fell 4.3% to $54.00 after a filing showed CFO Raju Prasad exercised and sold 29,700 shares under a preset trading plan. The move comes ahead of the company’s Jan. 12 slot at the J.P. Morgan Healthcare Conference and an expected mid-February earnings report. Gene-editing peers also traded lower. CASGEVY revenue and rollout remain key investor focus.
9 January 2026
·······
CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

CRISPR Therapeutics shares closed down 1.4% at $52.44 on Dec. 31, the final trading day of 2025. U.S. markets were shut Jan. 1 for New Year’s. Investors are watching for early-2026 updates on Casgevy’s rollout and the next earnings schedule as trading resumes Jan. 2. Biotech ETFs were little changed in light year-end trading.
2 January 2026
······
Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

The FDA will announce a new fast-track approval process for personalized gene-editing therapies in early November, sending CRISPR Therapeutics shares up 8% and Editas up 12%. CRSP reported over 90% mRNA correction in preclinical CTX460 data and will present Phase 1 CTX310 results at the AHA conference Nov. 8. Intellia paused a TTR amyloidosis trial after a liver injury, causing its stock to fall 46%.
2 November 2025
······

Stock Market Today

  • ARK Innovation ETF (ARKK) Falls Below 200-Day Moving Average at $46.28
    April 23, 2026, 4:43 PM EDT. Shares of ARK Innovation ETF (ARKK) dipped below its 200-day moving average of $46.28 on Thursday, trading as low as $45.45. This technical indicator, followed by investors to gauge trend direction, signals potential bearish momentum. ARKK shares were down about 1.1% on the day. The ETF's 52-week range spans from $33.76 to $54.52, with the latest trade at $46.09. This move below the key moving average could attract increased market attention on ARKK's near-term trajectory amid ongoing volatility in tech-focused funds.

Latest article

Lucid Group stock tumbles as Uber stake fails to ease funding worries

Lucid Group stock tumbles as Uber stake fails to ease funding worries

23 April 2026
Lucid Group shares fell 9.6% to $6.25 Thursday after Uber disclosed an 11.52% stake, totaling 37.75 million shares, in a regulatory filing. The drop followed Lucid’s $1.05 billion capital raise last week, including $500 million from Uber and $550 million from Saudi Arabia’s PIF affiliate. Lucid produced 5,500 vehicles and delivered 3,093 in Q1, missing estimates after a supplier issue halted Gravity SUV deliveries.
Palantir Wins $300 Million USDA Deal Ahead of Key May Earnings

Palantir Wins $300 Million USDA Deal Ahead of Key May Earnings

23 April 2026
Palantir signed a $300 million software agreement with the U.S. Department of Agriculture, expanding its government business ahead of its May 4 earnings report. Shares fell 7.2% Thursday despite the deal. The USDA said Palantir’s platform enabled rapid rollout of February’s $11 billion Farmer Bridge Assistance Program. The contract is a Blanket Purchase Agreement, allowing repeated orders over time rather than a single payment.
Go toTop